MAHALIFE Share Price Today - Mahamaya Lifesciences on NSE/BSE

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
UPL	571.00	#1 48,202.07	21.10	#1 52,502.00	11.41	#1 2,220	58.52	44.43
PI Industries	2,420.10	36,717.30	32.27	7,024.40	-15.59	1,321	-38.95	31.03
Sumitomo Chemical	517.85	25,848.26	45.04	3,385.00	3.56	543	20.44	44.91
Bayer Crop Science	4,048.70	18,195.70	24.96	5,770.00	3.16	689	15.39	38.79
Sharda Cropchem	783.75	7,071.03	#1 11.43	5,409.80	23.53	681	-38.38	39.98
Dhanuka Agritech	976.10	4,400.10	14.81	2,071.30	15.49	297	27.97	36.81
Rallis	209.63	4,076.65	31.33	2,631.40	6.54	164	-274.07	37.00
NACL Industries	171.63	4,020.32	329.81	1,587.30	#1 27.74	5	60.00	41.60
Bhagiradha Chemicals & Industries	277.90	3,603.50	133.21	538.30	19.68	18	#1 232.50	46.75
GSP Crop Science	626.60	2,914.86	29.53	1,517.11	16.60	91	16.81	70.56

Quarterly Financials	Dec 2024	Mar 2025
Revenue	0	118
Expenses	0	109
EBITDA	0	10
Operating Profit %	0 %	8 %
Depreciation	0	1
Interest	0	3
Profit Before Tax	0	7
Tax	0	2
Net Profit	0	5
EPS in ₹	0.00	3.04

Balance Sheet	2022	2023	2024	2025	2026
Total Assets	56	78	112	188	310
Fixed Assets	20	21	22	27	43
Current Assets	33	54	87	157	267
Capital Work in Progress	2	2	3	4	6
Investments	0	0	0	0	141
Other Assets	34	54	88	157	0
Total Equity & Liabilities	56	78	112	188	310
Current Liabilities	30	48	78	132	183
Non Current Liabilities	10	11	9	7	5
Total Equity	16	19	25	49	122
Reserve & Surplus	15	18	23	32	99
Share Capital	1	1	1	18	23

Cash Flow	2022	2023	2024	2025
Net Cash Flow	0	1	-0	1
Investing Activities	-3	-3	-2	-8
Operating Activities	2	1	-23	1
Financing Activities	1	2	24	9

% Holding	Feb 2025	Oct 2025	Nov 2025	Mar 2026
Promoter	77.27 %	77.27 %	56.35 %	56.35 %
FIIs	0.00 %	0.00 %	6.39 %	4.77 %
DIIs	0.00 %	0.00 %	4.67 %	2.52 %
Government	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	0.00 %	0.00 %	12.72 %	10.65 %
Others	22.73 %	22.73 %	19.88 %	25.71 %
No of Share Holders	18	18	1,034	584

Record Date	Corporate Action	Information	Announcement Day	LTP at Annoucement	LTP at Record Day
29 Sept 2026	Annual General Meeting	NA	29 Sept 2026	200.10	181.75
02 Dec 2025	Quarterly Result Announcement	NA	02 Dec 2025	116.35	115.55
25 May 2026	Quarterly Result Announcement	NA	25 May 2026	172.00	170.00

About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104

Mahamaya Lifesciences

Company News

Peer Comparison Compare Peers on Screener

Quarterly Financial Results

Balance Sheet

Cash Flow

Share Holding

Corporate Action

Announcements

Technical Indicators